Stockscreener 앱 받기
6.89
0.86%
0.05
전일 마감가:
$6.94
열려 있는:
$6.8
하루 거래량:
1.25M
Relative Volume:
0.75
시가총액:
$1.20B
수익:
$25.55M
순이익/손실:
$-341.97M
주가수익비율:
-2.4607
EPS:
-2.8
순현금흐름:
$-304.44M
1주 성능:
-6.91%
1개월 성능:
+27.74%
6개월 성능:
+115.38%
1년 성능:
+19.66%
1일 변동 폭
$6.76
$7.035
1주일 범위
$6.64
$7.64
52주 변동 폭
$1.775
$7.64
릴레이 테라퓨틱스 Stock (RLAY) Company Profile
명칭
Relay Therapeutics Inc
전화
617-370-8837
주소
60 HAMPSHIRE STREET, CAMBRIDGE
RLAY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RLAY
Relay Therapeutics Inc
|
6.935 | 1.20B | 25.55M | -341.97M | -304.44M | -2.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.69 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.03 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.96 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
830.90 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.67 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
릴레이 테라퓨틱스 Stock (RLAY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-04 | 재개 | Guggenheim | Buy |
| 2025-04-17 | 개시 | Wells Fargo | Equal Weight |
| 2024-09-10 | 재개 | Goldman | Buy |
| 2024-09-10 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-09-10 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-05-10 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2023-04-20 | 업그레이드 | Jefferies | Underperform → Hold |
| 2023-04-19 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-04-13 | 개시 | Raymond James | Outperform |
| 2023-02-03 | 개시 | Oppenheimer | Outperform |
| 2022-09-30 | 개시 | Barclays | Equal Weight |
| 2022-09-02 | 개시 | Stifel | Buy |
| 2022-06-06 | 개시 | Jefferies | Underperform |
| 2022-02-01 | 개시 | Berenberg | Buy |
| 2021-07-21 | 개시 | BofA Securities | Buy |
| 2020-12-15 | 재확인 | H.C. Wainwright | Buy |
| 2020-12-08 | 개시 | JMP Securities | Mkt Outperform |
| 2020-11-05 | 개시 | H.C. Wainwright | Buy |
| 2020-08-10 | 개시 | Cowen | Outperform |
| 2020-08-10 | 개시 | Goldman | Buy |
| 2020-08-10 | 개시 | Guggenheim | Buy |
| 2020-08-10 | 개시 | JP Morgan | Neutral |
모두보기
릴레이 테라퓨틱스 주식(RLAY)의 최신 뉴스
Why hedge funds are buying Relay Therapeutics Inc. stockJuly 2025 Institutional & Fast Momentum Stock Entry Tips - newser.com
How Relay Therapeutics Inc. stock compares to growth peersJuly 2025 Sentiment & Low Drawdown Momentum Trade Ideas - newser.com
Does Relay Therapeutics Inc. show high probability of reboundMarket Growth Summary & Verified Entry Point Detection - newser.com
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in November - Investing News Network
Relay Therapeutics (NASDAQ: RLAY) to join Guggenheim, Jefferies chats on Nov. 10 & 19 - Stock Titan
Published on: 2025-11-03 09:01:58 - newser.com
Has Relay Therapeutics Inc. found a price floorShort Setup & Capital Efficient Trade Techniques - newser.com
Published on: 2025-11-03 06:18:27 - newser.com
What machine learning models say about Relay Therapeutics Inc.Quarterly Investment Review & Weekly Breakout Stock Alerts - newser.com
Is Relay Therapeutics Inc. stock a top momentum play2025 Key Highlights & Detailed Earnings Play Alerts - newser.com
Published on: 2025-11-03 01:59:20 - newser.com
Backtesting results for Relay Therapeutics Inc. trading strategiesJuly 2025 Outlook & Long-Term Investment Growth Plans - newser.com
How to forecast Relay Therapeutics Inc. trends using time seriesPortfolio Risk Summary & Low Drawdown Trading Techniques - newser.com
Building trade automation scripts for Relay Therapeutics Inc.2025 Key Lessons & Daily Technical Forecast Reports - newser.com
How to use a screener to detect Relay Therapeutics Inc. breakouts2025 Stock Rankings & Weekly Watchlist of Top Performers - newser.com
Using Ichimoku Cloud for Relay Therapeutics Inc. technicalsMarket Sentiment Report & Daily Growth Stock Tips - newser.com
Published on: 2025-11-02 22:47:47 - newser.com
Why retail investors favor Relay Therapeutics Inc. stockJuly 2025 Sentiment & Entry Point Confirmation Alerts - newser.com
Regression analysis insights on Relay Therapeutics Inc. performanceShare Buyback & Consistent Return Strategy Ideas - newser.com
Relay Therapeutics Inc.’s volatility index tracking explained2025 Breakouts & Breakdowns & Consistent Income Trade Ideas - newser.com
Key metrics from Relay Therapeutics Inc.’s quarterly dataGap Up & Verified Entry Point Signals - newser.com
Analyzing recovery setups for Relay Therapeutics Inc. investorsJuly 2025 Fed Impact & High Yield Equity Trading Tips - newser.com
Relay Therapeutics (NASDAQ:RLAY) Insider Donald Bergstrom Sells 30,897 Shares - MarketBeat
Peter Rahmer Sells 21,394 Shares of Relay Therapeutics (NASDAQ:RLAY) Stock - MarketBeat
Relay Therapeutics (NASDAQ:RLAY) Insider Peter Rahmer Sells 19,135 Shares - MarketBeat
Insider Selling: Relay Therapeutics (NASDAQ:RLAY) CFO Sells 21,664 Shares of Stock - MarketBeat
What drives Relay Therapeutics Inc stock priceValue Traps to Avoid & Join 100,000+ Investors Already Learning - earlytimes.in
릴레이 테라퓨틱스 (RLAY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
릴레이 테라퓨틱스 주식 (RLAY) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Rahmer Peter | See remarks |
Oct 28 '25 |
Sale |
7.29 |
19,135 |
139,494 |
358,863 |
| Catinazzo Thomas | Chief Financial Officer |
Oct 28 '25 |
Sale |
7.29 |
21,664 |
157,931 |
313,631 |
| Bergstrom Donald A | President, R&D |
Oct 28 '25 |
Sale |
7.29 |
30,897 |
225,239 |
521,823 |
1.29%
0.56%
자본화:
|
볼륨(24시간):